About Curesponse
Curesponse is a company based in Rehovot (Israel) founded in 2018 by Guy Neev, Nancy Gavert, and Ravid Straussman.. Curesponse has raised $14 million across 2 funding rounds from investors including aMoon and NCL. Curesponse offers products and services including cResponse™. Curesponse operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others.
- Headquarter Rehovot, Israel
- Founders Guy Neev, Nancy Gavert, Ravid Straussman
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14 M (USD)
in 2 rounds
-
Latest Funding Round
$8 M (USD), Series B
Nov 15, 2021
-
Investors
aMoon
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Curesponse
Curesponse offers a comprehensive portfolio of products and services, including cResponse™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Evaluates cancer therapies on biopsies for accurate treatment predictions
Unlock access to complete
Unlock access to complete
Funding Insights of Curesponse
Curesponse has successfully raised a total of $14M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $8 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $8.0M
-
First Round
First Round
(05 Jun 2020)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series B - Curesponse | Valuation |
investors |
|
| Jun, 2020 | Amount | Series A - Curesponse | Valuation | aMoon , NCL |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Curesponse
Curesponse has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include aMoon and NCL. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in healthcare are focused on by aMoon.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Curesponse
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Curesponse
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Curesponse Comparisons
Competitors of Curesponse
Curesponse operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Curesponse
Frequently Asked Questions about Curesponse
When was Curesponse founded?
Curesponse was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Curesponse located?
Curesponse is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.
Who is the current CEO of Curesponse?
Guy Neev is the current CEO of Curesponse. They have also founded this company.
Is Curesponse a funded company?
Curesponse is a funded company, having raised a total of $14M across 2 funding rounds to date. The company's 1st funding round was a Series A of $6M, raised on Jun 05, 2020.
What does Curesponse do?
Founded in 2018 in Rehovot, Israel, Curesponse operates in the biotechnology sector, focusing on oncology. A proprietary tissue culture system is utilized to preserve cancer tissue, including vasculature and immune components, for studying tumor behavior in vivo. The cResponse test is offered, evaluating patient tumor samples from biopsies or surgeries against various treatments. This is integrated with genomic analysis to tailor therapies for individual cancer patients.
Who are the top competitors of Curesponse?
Curesponse's top competitors include Guardant Health, Strand Life Sciences and Sutro Biopharma.
What products or services does Curesponse offer?
Curesponse offers cResponse™.
Who are Curesponse's investors?
Curesponse has 2 investors. Key investors include aMoon, and NCL.